Infusion Pumps and Accessories Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)

Infusion Pumps and Accessories Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)

The infusion pumps and accessories market was valued at USD 10,539.46 million in 2021, and it is expected to reach USD 14,426.09 million by 2027, registering a CAGR of 5.4% during the forecast period (2022-2027).

The COVID-19 pandemic brought infusion pumps into the forefront since the demand for infusion pumps surged considerably during the COVID-19 lockdown, as the number of COVID-19 cases increased at a faster rate with growing hospital admissions. The COVID-19 pandemic had a moderate impact on the global infusion pump and accessories industry. For instance, in July 2020, the United States Food and Drug Administration (USFDA) issued an emergency use authorization (EUA) to increase the availability of infusion pumps and infusion pump accessories, which were an integral part of the treatment of patients during the COVID-19 pandemic. Additionally, in May 2020, the United States Food and Drug Administration (USFDA) issued an umbrella emergency use authorization (EUA) for infusion pumps and infusion pump accessories for use by healthcare providers to treat conditions caused by COVID-19 for the controlled infusion of medications, total parenteral nutrition, and other fluid requirements. This guideline has had a positive impact on the growth of the market in the recent past and is expected to continue to propel it at higher growth rates even in the future. Thus, COVID-19 had a significant impact on the infusion pump and accessories market.

The global infusion pumps and accessories market is primarily driven by the rising incidence of chronic diseases, such as cancer and others, coupled with the rising adoption of these devices, owing to the broadening applications of infusion pumps. Currently, infusion pumps are widely used in chemotherapy, diabetes management, and many other applications. The rising prevalence of these diseases worldwide is creating ample opportunities for the market to grow. For instance, according to the International Diabetes Federation (IDF) Diabetes Atlas, Tenth Edition, 2021 statistics reported that there were approximately 537 million adults (aged 20-79 years) suffering from diabetes in 2021. The same source estimated that the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Thus, with the rise in diabetic cases, there is an increased need for insulin pumps, which drives the growth of the market. Similarly, a chemotherapy infusion pump is recommended for patients with metastatic colorectal cancer that has spread to the liver. Thus, increasing the incidence of cancer cases will also drive the growth of infusion pumps. For instance, according to the GLOBOCAN 2020 statistics, there were 1.15 million new cases of colon cancer in 2020 worldwide, and this number is expected to reach 1.92 million by the year 2040.

In addition, technological advancements in device technology, companies’ efforts in innovating products to meet safety requirements and increase the adoption of devices are likely to fuel market growth. For instance, in February 2021, United Therapeutics launched the Remunity Pump for remodulin, which helps to improve the lives of patients with pulmonary arterial hypertension (PAH). Also, the development of infusion pump devices by the key market players is propelling the growth of this market. For instance, in February 2021, Mindray Medical launched BeneFusion E series-ESP, EVP, and EDS, new infusion systems for expanding its product portfolio.

Hence, owing to all the aforementioned factors, the market is anticipated to grow at high growth rates. However, the higher cost of infusion pumps and the safety issues associated with them may slow down the growth of this market.

Key Market TrendsVolumetric Infusion Pumps Segment Is Expected to Witness a Significant Growth Over the Forecast Period

Volumetric infusion pumps have a wide range of applications in disease management and parenteral nutrition, owing to which the market value for volumetric infusion pumps is the highest compared to the markets for other pumps. The safety, accuracy, and simplicity of infusion pumps in the treatment of many therapeutic areas contribute to the high demand for these pumps.

The volumetric infusion pump segment is driven by its wide applications, advantages, increasing use, and growing product launch in developing and developed countries. For instance, in March 2022, Fresenius Kabi received regulatory clearance from the United States Food and Drug Administration (USFDA) for its wireless Agilia connect infusion system, which includes the Agilia volumetric pump and the Agilia syringe pump with vigilant software suite-Vigilant Master Med technology. The Agilia Connect volumetric pump and syringe pump is one of the first to be cleared by following TIR101 standards, which were developed by the Association for the Advancement of Medical Instrumentation (AAMI) in 2021. This product offering has enabled the centralized distribution of drug libraries; warehousing of infusion data for reporting and analysis; and wireless maintenance and calibration of devices.

Additionally, the major players are focusing on research and development activities, which is expected to boost the growth of the market segment. For instance, in November 2021, Zealand Pharma and DEKA Research & Development Corp. signed an agreement to advance the development of an infusion pump that can be used with dasiglucagon for the treatment of congenital hyperinsulinism (CHI).

Thus, all the aforementioned factors, such as the rising prevalence of chronic diseases and technological advancement, boost the segment's growth.

North America is Expected to Dominate the Market Over the Forecast Period

North America is expected to hold a major share in the infusion pumps and accessories market. The growth of the market is driven by the surge in chronic disorders and the rapid adoption of technologically advanced products by patients and physicians both for regular treatment of chronic disease conditions. For instance, according to the American Cancer Society's 2022 statistics, there will be 1,918,030 new cancer cases in the United States in 2022.

Additionally, the International Diabetes Federation (IDF) Diabetes Atlas, Tenth Edition statistics reported that 32.2 million people were living with diabetes in the United States in 2021, and this number is estimated to increase by 36.3 million by the end of 2045. Thus, the high and increasing incidence of chronic diseases like cancer and diabetes is expected to drive this market's growth.

Additionally, the growth of the market is also driven by the rapid adoption of favorable reimbursement policies that aid the growth in the region. The United States healthcare reimbursement system consists of a mix of public and private third-party coverage, in which employers, individuals, and the government all contribute to the costs related to healthcare. Individuals and employers pay premiums to private insurance companies to cover healthcare costs; government coverage is provided at the federal level (Medicare, Department of Defense, Bureau of Indian Affairs); and state level (Medicaid) to specific populations; and private insurers may also provide care coverage to citizens that receive government insurance (Medicare/Medicaid).

Also, for the past few decades, the duration of inpatient stays has increased, resulting in an increased demand for infusion pumps for these patients. For instance, in 2022, the American Hospital Association reported that in 2021, over 36.2 million hospital admissions were registered in the United States. The growing demand for premium-priced infusion pump systems to improve the quality of care for patients is expected to play a key role in the growth of the infusion pump market in North America.

Hence, owing to all the aforementioned factors, the market is anticipated to grow exponentially in the North American region.

Competitive Landscape

The market for infusion pumps and accessories is highly competitive and fragmented due to the presence of a large number of global and local players. Due to technological advancements, many small- and mid-sized companies are focusing on market penetration to grab the market share. Some of the key global players in this market are Baxter International Inc., Becton, Dickinson and Company, Braun Melsungen AG, CareFusion Corporation, Eli Lilly and Company, F. Hoffmann-la Roche Ltd, Fresenius Kabi, ICU Medical Inc., Johnson & Johnson, Medtronic Inc., Nipro Corporation, Option Care Health Inc., Pfizer Inc., and Terumo Corporation, among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.